HomeCompareWXIBF vs PM

WXIBF vs PM: Dividend Comparison 2026

WXIBF yields 43.48% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WXIBF wins by $230.2K in total portfolio value
10 years
WXIBF
WXIBF
● Live price
43.48%
Share price
$4.60
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$279.7K
Annual income
$50,636.72
Full WXIBF calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — WXIBF vs PM

📍 WXIBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWXIBFPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WXIBF + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WXIBF pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WXIBF
Annual income on $10K today (after 15% tax)
$3,695.65/yr
After 10yr DRIP, annual income (after tax)
$43,041.21/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, WXIBF beats the other by $40,923.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WXIBF + PM for your $10,000?

WXIBF: 50%PM: 50%
100% PM50/50100% WXIBF
Portfolio after 10yr
$164.7K
Annual income
$26,564.37/yr
Blended yield
16.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

WXIBF
No analyst data
Altman Z
10.0
Piotroski
9/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WXIBF buys
0
PM buys
0
No recent congressional trades found for WXIBF or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWXIBFPM
Forward yield43.48%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$279.7K$49.6K
Annual income after 10y$50,636.72$2,492.02
Total dividends collected$215.5K$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: WXIBF vs PM ($10,000, DRIP)

YearWXIBF PortfolioWXIBF Income/yrPM PortfolioPM Income/yrGap
1← crossover$15,048$4,347.83$11,648$408.29+$3.4KWXIBF
2$22,216$6,114.52$13,589$495.90+$8.6KWXIBF
3$32,207$8,436.54$15,877$603.21+$16.3KWXIBF
4$45,893$11,430.77$18,580$734.88+$27.3KWXIBF
5$64,327$15,222.29$21,781$896.75+$42.5KWXIBF
6$88,771$19,941.10$25,578$1,096.12+$63.2KWXIBF
7$120,704$25,718.32$30,092$1,342.17+$90.6KWXIBF
8$161,835$32,681.83$35,470$1,646.46+$126.4KWXIBF
9$214,115$40,951.88$41,892$2,023.58+$172.2KWXIBF
10$279,740$50,636.72$49,578$2,492.02+$230.2KWXIBF

WXIBF vs PM: Complete Analysis 2026

WXIBFStock

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.

Full WXIBF Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this WXIBF vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WXIBF vs SCHDWXIBF vs JEPIWXIBF vs OWXIBF vs KOWXIBF vs MAINWXIBF vs MOWXIBF vs BTIWXIBF vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.